390 related articles for article (PubMed ID: 26126965)
21. Circulating Cytokines Could Not Be Good Prognostic Biomarkers in a Mouse Model of Amyotrophic Lateral Sclerosis.
Moreno-Martínez L; de la Torre M; Toivonen JM; Zaragoza P; García-Redondo A; Calvo AC; Osta R
Front Immunol; 2019; 10():801. PubMed ID: 31031774
[No Abstract] [Full Text] [Related]
22. Panel of Oxidative Stress and Inflammatory Biomarkers in ALS: A Pilot Study.
Blasco H; Garcon G; Patin F; Veyrat-Durebex C; Boyer J; Devos D; Vourc'h P; Andres CR; Corcia P
Can J Neurol Sci; 2017 Jan; 44(1):90-95. PubMed ID: 27774920
[TBL] [Abstract][Full Text] [Related]
23. Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression.
Tortelli R; Ruggieri M; Cortese R; D'Errico E; Capozzo R; Leo A; Mastrapasqua M; Zoccolella S; Leante R; Livrea P; Logroscino G; Simone IL
Eur J Neurol; 2012 Dec; 19(12):1561-7. PubMed ID: 22680408
[TBL] [Abstract][Full Text] [Related]
24. Comparison of multiplex platforms for cytokine assessments and their potential use for biomarker profiling in multiple sclerosis.
Malekzadeh A; Twaalfhoven H; Wijnstok NJ; Killestein J; Blankenstein MA; Teunissen CE
Cytokine; 2017 Mar; 91():145-152. PubMed ID: 28082233
[TBL] [Abstract][Full Text] [Related]
25. The MITOS system predicts long-term survival in amyotrophic lateral sclerosis.
Tramacere I; Dalla Bella E; Chiò A; Mora G; Filippini G; Lauria G;
J Neurol Neurosurg Psychiatry; 2015 Nov; 86(11):1180-5. PubMed ID: 25886781
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-6 and amyotrophic lateral sclerosis.
Pronto-Laborinho A; Pinto S; Gromicho M; Pereira M; Swash M; de Carvalho M
J Neurol Sci; 2019 Mar; 398():50-53. PubMed ID: 30682521
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net.
Steinacker P; Huss A; Mayer B; Grehl T; Grosskreutz J; Borck G; Kuhle J; Lulé D; Meyer T; Oeckl P; Petri S; Weishaupt J; Ludolph AC; Otto M
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Feb; 18(1-2):112-119. PubMed ID: 27819158
[TBL] [Abstract][Full Text] [Related]
28. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
[TBL] [Abstract][Full Text] [Related]
29. [Revised amyotrophic lateral sclerosis functional rating scale at time of diagnosis predicts survival time in amyotrophic lateral sclerosis].
Liu XX; Fan DS; Zhang J; Zhang S; Zheng JY
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2472-5. PubMed ID: 20137433
[TBL] [Abstract][Full Text] [Related]
30. Neurofilaments as Biomarkers for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
Xu Z; Henderson RD; David M; McCombe PA
PLoS One; 2016; 11(10):e0164625. PubMed ID: 27732645
[TBL] [Abstract][Full Text] [Related]
31. Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics.
Lawton KA; Brown MV; Alexander D; Li Z; Wulff JE; Lawson R; Jaffa M; Milburn MV; Ryals JA; Bowser R; Cudkowicz ME; Berry JD;
Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):362-70. PubMed ID: 24984169
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-15 and interleukin-12 are elevated in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Rentzos M; Rombos A; Nikolaou C; Zoga M; Zouvelou V; Dimitrakopoulos A; Alexakis T; Tsoutsou A; Samakovli A; Michalopoulou M; Evdokimidis I
Eur Neurol; 2010; 63(5):285-90. PubMed ID: 20407265
[TBL] [Abstract][Full Text] [Related]
33. A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis.
Mitchell RM; Freeman WM; Randazzo WT; Stephens HE; Beard JL; Simmons Z; Connor JR
Neurology; 2009 Jan; 72(1):14-9. PubMed ID: 18987350
[TBL] [Abstract][Full Text] [Related]
34. Role of diffusion tensor imaging or magnetic resonance spectroscopy in the diagnosis and disability assessment of amyotrophic lateral sclerosis.
Liu C; Jiang R; Yi X; Zhu W; Bu B
J Neurol Sci; 2015 Jan; 348(1-2):206-10. PubMed ID: 25524526
[TBL] [Abstract][Full Text] [Related]
35. Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis.
Tanaka M; Kikuchi H; Ishizu T; Minohara M; Osoegawa M; Motomura K; Tateishi T; Ohyagi Y; Kira J
J Neuropathol Exp Neurol; 2006 Aug; 65(8):816-25. PubMed ID: 16896315
[TBL] [Abstract][Full Text] [Related]
36. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Kawajiri M; Mogi M; Higaki N; Tateishi T; Ohyagi Y; Horiuchi M; Miki T; Kira JI
Acta Neurol Scand; 2009 May; 119(5):341-4. PubMed ID: 18798831
[TBL] [Abstract][Full Text] [Related]
37. Association between nutritional status and disease severity using the amyotrophic lateral sclerosis (ALS) functional rating scale in ALS patients.
Park Y; Park J; Kim Y; Baek H; Kim SH
Nutrition; 2015; 31(11-12):1362-7. PubMed ID: 26429656
[TBL] [Abstract][Full Text] [Related]
38. Reduced levels of alpha-1-antitrypsin in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a novel approach for a potential treatment.
Wormser U; Mandrioli J; Vinceti M; Fini N; Sintov A; Brodsky B; Proskura E; Finkelstein Y
J Neuroinflammation; 2016 Jun; 13(1):131. PubMed ID: 27245439
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.
Han Y; Ripley B; Serada S; Naka T; Fujimoto M
PLoS One; 2016; 11(4):e0153399. PubMed ID: 27070121
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of humoral immune response in adaptive immunity in ALS patients during disease progression.
Saleh IA; Zesiewicz T; Xie Y; Sullivan KL; Miller AM; Kuzmin-Nichols N; Sanberg PR; Garbuzova-Davis S
J Neuroimmunol; 2009 Oct; 215(1-2):96-101. PubMed ID: 19682755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
